Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

In this latest installment of Noid Knowledge, Jason Wilson from the Curious About Cannabis podcast discusses with our host Evan Friedmann and guests TJ Martin, Ian Oswald, and Kyle Boyar, their experiences at the American Chemical Society (ACS) conference in San Diego. Wilson shares insights from a conversation with colleagues about their research on volatile sulfur compounds (VSCs) in cannabis, which contribute to its aroma. They found that while most VSCs were present in low concentrations, some strains like Gelato and GMO had higher levels. They also discussed the importance of proper packaging, noting that mylar bags can effectively retain these compounds. The conversation highlights the need for better analytical methods and open-access research to advance the cannabis industry.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

Texas Governor Greg Abbott issues an executive order to regulate product sales, requiring ID checks and testing.

New York's legal cannabis sales top $2 billion, with 46 new licenses approved. The state is prioritizing social equity and new education panels.

In this interview, Steve Allin, director of the International Hemp Building Association shares insights on the versatility and benefits of hemp as a crop and as a material used in construction.

Thailand's cannabis laws are evolving. A new Prime Minister brings hope for a discussion on legalizing cannabis.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

What's driving the cannabis pricing crisis? Test your knowledge regarding the market forces and trends that are reshaping the industry for 2025.

Citing risks to children, health, and public safety, nine Congress members sent a letter to Attorney General Pam Bondi and President Donald Trump, opposing the rescheduling of cannabis.

The Maryland Comptroller reports nearly $18.4 million in Q2 cannabis tax revenue. The Central region, including Baltimore, generated the most income.

Nebraska’s cannabis commission approves restrictive rules, limiting patient access and business licenses.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Recent research highlights the potential of cannabinoids as alternative treatments for atopic dermatitis, showcasing their anti-inflammatory and antibacterial properties.

Delaware's first month of recreational marijuana sales was a success at over $7 million, but the veto of SB 75 shows an ongoing zoning debate.